Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial (Q37206183)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2009

Language	Label	Description	Also known as
English	Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial	scientific article published on May 2009

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial (English)

1 reference

Europe PubMed Central

18 August 2017

0 references

type 2 diabetes

0 references

5

object named as

Merryn Voysey

0 references

Michael d'Emden

object named as

Michael C D'Emden

6

0 references

7

object named as

Markku Laakso

1 reference

Europe PubMed Central

18 August 2017

author name string

Kushwin Rajamani

1

1 reference

Europe PubMed Central

18 August 2017

Peter G Colman

2

1 reference

Europe PubMed Central

18 August 2017

Li Ping Li

3

1 reference

Europe PubMed Central

18 August 2017

James D Best

4

1 reference

Europe PubMed Central

18 August 2017

John R Baker

8

1 reference

Europe PubMed Central

18 August 2017

Anthony C Keech

9

1 reference

Europe PubMed Central

18 August 2017

FIELD study investigators

10

1 reference

Europe PubMed Central

18 August 2017

language of work or name

0 references

publication date

1 May 2009

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

373

1 reference

Europe PubMed Central

18 August 2017

1780-1788

1 reference

Europe PubMed Central

18 August 2017

9677

1 reference

Europe PubMed Central

18 August 2017

Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

6 September 2017

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

6 September 2017

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

6 September 2017

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

6 September 2017

PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

6 September 2017

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

6 September 2017

Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

6 September 2017

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

6 September 2017

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

6 September 2017

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

6 September 2017

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

6 September 2017

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

6 September 2017

No adjustments are needed for multiple comparisons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

6 September 2017

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

6 September 2017

Intermittent claudication. A risk profile from The Framingham Heart Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

26 June 2018

Fenofibrate activates AMPK and increases eNOS phosphorylation in HUVEC.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

3 September 2018

Lower extremity minor amputations: the roles of diabetes mellitus and timing of revascularization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

3 September 2018

Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

3 September 2018

Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

3 September 2018

Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

3 September 2018

The health care costs of diabetic peripheral neuropathy in the US.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

3 September 2018

Economic costs of diabetes in the US in 2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

3 September 2018

Health-related quality of life in patients with diabetes mellitus and foot ulcers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

3 September 2018

Dynamic balanced randomization for clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2687887

3 September 2018

Lower-extremity amputation in people with diabetes. Epidemiology and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960698-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960698-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960698-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Fenofibrate regulates retinal endothelial cell survival through the AMPK signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960698-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Malondialdehyde serum concentration in type 1 diabetic with and without retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960698-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathways to diabetic limb amputation. Basis for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960698-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: The Fremantle Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960698-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival of the diabetic foot: the role of a specialized foot clinic

1 reference

https://pubmed.ncbi.nlm.nih.gov/19465233

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S0140-6736(09)60698-X

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37206183&oldid=1694451497"